BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF GOLIMUMAB AS AN ADDITIONAL TREATMENT OPTION FOR PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Scaccabarozzi, L. [1 ]
Asano, E. [1 ]
Guimaraes, T. B. [1 ]
机构：
[1] Janssen, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.1038
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY20
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT OF GOLIMUMAB IN THE ANTI-TNF TREATMENT OF RHEUMATOID ARTHRITIS, AKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2012, 15 (07) : A441 - A441
  • [2] Persistence associated with the use of biologicals for the treatment of ankylosing spondylitis in the Brazilian public health system
    dos Santos A. Santos, Barbara Rodrigues Alvernaz
    Oliveira, Gerusa A.
    Morgado, Marina
    Brandao, Natalia Dias
    Guerra Junior, Augusto Afonso
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 170 - 170
  • [3] Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system
    Azevedo, Valderilio Feijo
    Rossetto, Chayanne N.
    Lorencetti, Pedro G.
    Tramontin, Mariana Y.
    Fornazari, Bruna
    Araujo, Denizar V.
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2016, 56 (02) : 131 - 137
  • [4] COST OF DRUG THERAPY FOR ANKYLOSING SPONDYLITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Machado, M. A. A.
    Ferre, F.
    Almeida, A. M.
    Andrade, E., I
    Cherchiglia, M. L.
    Guerra Junior, A. A.
    Moura, C. S.
    Acurcio, F. A.
    VALUE IN HEALTH, 2014, 17 (03) : A46 - A46
  • [5] Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis
    Purmonen, Timo
    Tormalehto, Soili
    Wahlman, Hanna
    Puolakka, Kari
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 151 - 157
  • [6] Retraction Note: Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta‑analysis
    Jami Sayed Abdulla
    Jiandang Shi
    Brotendu Shekhar Roy
    Zhou Zhanwen
    Changhao Liu
    European Spine Journal, 2022, 31 : 1067 - 1067
  • [7] RETRACTED ARTICLE: Patients with ankylosing spondylitis treatment by golimumab: a systematic review and meta-analysis
    Jami Sayed Abdulla
    Jiandang Shi
    Brotendu Shekhar Roy
    Zhou Zhanwen
    Changhao Liu
    European Spine Journal, 2020, 29 : 1813 - 1822
  • [8] ADALIMUMAB, ETANERCEPT AND INFLIXIMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS-BUDGET IMPACT ANALYSIS ON POLISH NATIONAL HEALTH FUND
    Macioch, T.
    Niewada, M.
    Wrona, W.
    Golicki, D.
    Hermanowski, T.
    VALUE IN HEALTH, 2008, 11 (06) : A541 - A541
  • [9] COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF UPADACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Acayaba de Toledo, R.
    Arruda, M. S.
    Morais, C. G., V
    dos Santos, R.
    VALUE IN HEALTH, 2021, 24 : S16 - S17
  • [10] Budget impact of Transdermal Adhesives of Rivastigmine in Brazilian Public Health System
    Bueno, R. L. P.
    Gomes, M.
    Indelli, B.
    VALUE IN HEALTH, 2008, 11 (03) : A138 - A138
12345